Abstract:The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been rapidly spreading on a global scale and poses a great threat to human health. However, efficient indicators for disease severity have not been fully investigated. Here, we aim to investigate whether dynamic changes of lymphocyte counts can predict the deterioration of patients with COVID-19. We collected data from 2923 patients with laboratory-confirmed COVID-19. Patients were then screened, and we focused on 145 severe cases and 60 critical cases (29 recovered cases, 31 deaths). The length of hospitalization was divided into five time points, namely admission, 25%, 50%, 75% and discharge or death, according to the principle of interquartile distance. A series of laboratory findings and clinical data were collected and analyzed during hospitalization. The results showed that there were differences in levels of leukocytes, neutrophils and lymphocytes at almost every time point in the severe cases and 60 critical cases (29 recovered cases, 31 deaths). Further analysis showed that 70.2% of the COVID-19 cases had low circulating lymphocyte count, of which 64.1% were severe cases and 85.0% were critical cases (75.9% recovered cases and 93.5% died). Moreover, the lymphocyte count in dead cases was significantly lower than that of critical cases who recovered, at almost every time point in the critical groups. We also divided critical patients into group A (<1.1 x 10(9)/L) and group B (>1.1 x 10(9)/L) according to number of lymphocytes. Through survival analysis, we found that there was no significant difference in survival between group A and group B at admission (P = .3065). However, the survival rate according to lymphocyte levels in group A was significantly lower than that of group B at 25% hospital stay (on average day 6.5), 50% and 75% time points (P < .001). Lymphocyte counts that remain lower after the first week following symptom onset are highly predictive of in-hospital death of adults with COVID-19. This predictor may help clinicians identify patients with a poor prognosis and may be useful for guiding clinical decision-making at an early stage.

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19

Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19

Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients

Analysis of the Dynamic Relationship Between Immune Profiles and the Clinical Features of Patients with COVID-19

Dynamic Changes in Lymphocyte Populations and Their Relationship with Disease Severity and Outcome in COVID-19

Decreased T cell populations contribute to the increased severity of COVID-19

Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID‚Äź19: Implications for disease severity and prognosis

Dynamic Change in Lymphocyte Count in the Early Stage is a Potential Predictor of the Severity of COVID-19

Dynamic Behavior of Lymphocyte Subgroups Correlates with Clinical Outcomes in Human H7N9 Infection.

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study

Dynamic changes in routine blood parameters of a severe COVID-19 case

The dynamics of immune response in COVID‐19 patients with different illness severity

Lymphocyte Subsets As a Predictor of Severity and Prognosis in COVID-19 Patients.

Changes of lymphocyte and subsets counts and the correlation to the prognosis in COVID-19 patients

Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)

The characteristics and predictive role of lymphocyte subsets in COVID-19 patients

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

The clinical course and its correlated immune status in COVID-19 pneumonia

Lymphocyte Blood Levels That Remain Low Can Predict The Death Of Patients With Covid-19

The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study